Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Germany In-Vitro Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

Published by Mordor Intelligence Pvt Ltd Product code 391042
Published Content info 85 Pages
Delivery time: 2-3 business days
Back to Top
Germany In-Vitro Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)
Published: June 1, 2020 Content info: 85 Pages

The IVD market in Germany is the one of the largest in Europe. It involves development and manufacture of biological and chemical reagents, test kits, automated machines, and devices that are used to analyze body fluids. Most of the sector comprises of small and medium sized enterprises (SMEs). According to the German Diagnostics Industry Association (VDGH), the IVD and reagent market turnover recorded in 2017 amounted to roughly EUR 2-3 billion. Companies generated the bulk of their turnover with the reagents (86.5% of turnover). Instruments and services totaled 13.5% of turnover. Innovative developments in the IVD field are currently driven by four major trends: point-of-care testing, automation, digitalization, and the concept of personalize medicine. Some other factors contributing to the growth of market include rapid increase in the chronic and infectious disease population, technological advances, rapidly aging population, and advent of point of care diagnostics. Some of the factors limiting the growth of the market are a lack of proper reimbursement policies and cumbersome regulatory framework.

Key Market Trends

Molecular diagnostic segment dominates the Germany In-Vitro Diagnostics Market

Molecular diagnostics are used to analyze biological markers in the genome and proteome to detect pathogens or mutations. On the basis of technology used, molecular diagnostic devices can be segmented into chips and microarrays, mass spectroscopy, next-generation sequencing (NGS), polymerase chain reaction (PCR)-based methods, cytogenetics, and molecular imaging. Molecular diagnostics has emerged as one of the largest and fastest growing sectors of the IVD industry in Germany. This development is fueled by the introduction of powerful techniques, such as real-time polymerase chain reaction (PCR) and next generation sequencing (NGS), which allow the amplification and decoding of genetic and epigenetic information.

Competitive Landscape

Germany In-Vitro Diagnostics market has rapidly evolved over the last few years. Industry observed significant changes in adoting market strategies such as product developments, mergers and acquisitions in recent years. Thus, the Germany In-Vitro Diagnostics market has become a very competitive industry. Major companies in the market are Thermo Fischer Scientific Inc., Qiagen N.V., Abbott Laboratories, Siemens Healthcare GmbH and F. Hoffmann-La Roche AG among others

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Table of Contents
Product Code: 48203

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Increase in Chronic Diseases
    • 4.2.2 Increasing Number of Private Hospitals and Independent Testing Laboratories
    • 4.2.3 Increasing Demand for Point-of-Care Testing and Personalized Medicine
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulations
    • 4.3.2 Cumbersome Reimbursement Procedures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 Technique
    • 5.1.1 Clinical Chemistry
    • 5.1.2 Molecular Diagnostics
    • 5.1.3 Hematology
    • 5.1.4 Immuno Diagnostics
    • 5.1.5 Other Techniques
  • 5.2 Product
    • 5.2.1 Instrument
    • 5.2.2 Reagent
    • 5.2.3 Others
  • 5.3 Usability
    • 5.3.1 Disposable IVD Devices
    • 5.3.2 Reusable IVD Devices
  • 5.4 Application
    • 5.4.1 Infectious Disease
    • 5.4.2 Diabetes
    • 5.4.3 Cancer/Oncology
    • 5.4.4 Cardiology
    • 5.4.5 Autoimmune Disease
    • 5.4.6 Nephrology
    • 5.4.7 Other Applications
  • 5.5 End Users
    • 5.5.1 Diagnostic Laboratories
    • 5.5.2 Hospitals & Clinics
    • 5.5.3 Other End Users


  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Bio-Rad Laboratories Inc.
    • 6.1.4 bioMerieux SA
    • 6.1.5 Danaher Corporation
    • 6.1.6 Epigenomics Inc.
    • 6.1.7 F. Hoffmann-La Roche AG
    • 6.1.8 Johnson & Johnson
    • 6.1.9 Qiagen N.V.
    • 6.1.10 Siemens Healthcare GmbH


Back to Top